Reassessing Congenital Left Ventricular Diverticulum: A Comprehensive Review of Clinical Presentations, Imaging Characteristics, and Treatment Approaches - Top-Institutions - DentalSpire

Reassessing Congenital Left Ventricular Diverticulum: A Comprehensive Review of Clinical Presentations, Imaging Characteristics, and Treatment Approaches

  • By

  • Klevis Mihali

  • Lukas Harbaum

  • Julian Kreutz

  • Paolo Ciliberti

  • Aurelio Secinaro

  • Colin Joseph Mcmahon

  • Pier Paolo Bassareo

  • January 24, 2026

  • 0 min

Share

Top Institutions in Dental

Brief introduction explaining scope and methodology.

  • #1

    Boston Children's Hospital
    Boston Children's Hospital

    Boston, MA

    Key Differentiators

    • Pediatric Cardiology
    • Cardiac Imaging
    • Congenital Heart Surgery

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Adult Congenital Cardiology
    • Cardiac Imaging
    • Cardiothoracic Surgery

  • #3

    Texas Children's Hospital
    Texas Children's Hospital

    Houston, TX

    Key Differentiators

    • Pediatric Cardiology
    • Cardiac Imaging
    • Congenital Heart Surgery

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Adult and Pediatric Cardiology
    • Cardiac Imaging
    • Cardiothoracic Surgery

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Cardiac Imaging
    • Cardiothoracic Surgery

Original Source(s)

Reassessing Congenital Left Ventricular Diverticulum: A Comprehensive Review of Clinical Presentations, Imaging Characteristics, and Treatment Approaches

  • by Klevis Mihali, Lukas Harbaum, Julian Kreutz, Paolo Ciliberti, Aurelio Secinaro, Colin Joseph Mcmahon, Pier Paolo Bassareo

  • January 24, 2026

Related Content

Risk of cardiovascular events according to the severity of an exacerbation of chronic obstructive pulmonary disease

Tackling heart failure with multimodality preventive cardiology

Cardiovascular outcomes and mortality in diabetic multiple myeloma patients initiated on proteasome inhibitors according to prior use of glucagon-like peptide 1 agonists